Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

The Hemodynamics Effect of Levcromakalim After Glibenclamide Administration Assessed by High Resolution MRA Technique in a Randomized, Double-blind, Cross-over and Placebo-controlled Study With Healthy Volunteers

Next Previous
Trial Profile

The Hemodynamics Effect of Levcromakalim After Glibenclamide Administration Assessed by High Resolution MRA Technique in a Randomized, Double-blind, Cross-over and Placebo-controlled Study With Healthy Volunteers

Status: Recruiting
Phase of Trial: Phase II

Latest Information Update: 12 Jul 2022

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Lemakalim (Primary) ; Glibenclamide
  • Indications Hypertension
  • Focus Adverse reactions; Pharmacodynamics

Most Recent Events

  • 01 Jul 2022 This study was previously assessing the Effect of Levcromakalim After Glibenclamide Administration and now assessing the Effect of Glibenclamide on Levcromakalim and treatment arms are also amended.
  • 01 Jul 2022 Planned number of patients changed from 12 to 15.
  • 01 Jul 2022 Planned End Date changed from 30 Jun 2021 to 30 Aug 2023.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top